Matasar, M., Li, Z., Vassilakopoulos, T. P., Sancho, J., Viardot, A., McMillan, A., Dal, M. S., Pereira, J., Kim, J. S., Qiu, L., Batlevi, C. L., Ibrahim, R., Hernandez, J., McCall, B., Jiang, Y., Yan, M., Harris, W., Musick, L., Haioun, C. (2026). Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02849